Menu
Logo

Uptravi improves hemodynamic parameters

REFERENCE

1. Simonneau G, Torbicki A, Hoeper MM, et al. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. Eur Respir J. 2012; 40 (4): 874-880.

CP-266805